Retraction：Effects of Valsartan on Cardiovascular Morbidity and Mortality in High-Risk Hypertensive Patients With New-Onset Diabetes Mellitus

2012 ◽  
Author(s):  
Shinzo Kimura ◽  
Takahisa Sawada ◽  
Jun Shiraishi ◽  
Hiroyuki Yamada ◽  
Hiroaki Matsubara ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
High Risk ◽  
Cardiovascular Morbidity ◽  
Morbidity And Mortality ◽  
Hypertensive Patients ◽  
Onset Diabetes ◽  
Cardiovascular Morbidity And Mortality ◽  
New Onset Diabetes Mellitus ◽  
New Onset

scholarly journals Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial

2008 ◽  
Vol 22 (8) ◽  
pp. 520-527 ◽  
Author(s):  
T A Aksnes ◽  
S E Kjeldsen ◽  
M Rostrup ◽  
Ö Störset ◽  
T A Hua ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Hypertensive Patients ◽  
Onset Diabetes ◽  
New Onset Diabetes Mellitus ◽  
New Onset

Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial)

2008 ◽  
Vol 101 (5) ◽  
pp. 634-638 ◽  
Author(s):  
Tonje Amb Aksnes ◽  
Roland E. Schmieder ◽  
Sverre Erik Kjeldsen ◽  
Sajda Ghani ◽  
Tsushung Augie Hua ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Atrial Fibrillation ◽  
High Risk ◽  
Onset Diabetes ◽  
New Onset Diabetes Mellitus ◽  
New Onset

Selective ß1-Blockers Are Not Associated With New-onset Diabetes Mellitus in Hypertensive Patients

2018 ◽  
Vol 71 (1) ◽  
pp. 38-45 ◽  
Author(s):  
Yoonjee Park ◽  
Byoung Geol Choi ◽  
Seung-Woon Rha ◽  
Man Jong Baek ◽  
Yang Gi Ryu ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Hypertensive Patients ◽  
Onset Diabetes ◽  
New Onset Diabetes Mellitus ◽  
New Onset
Sign in / Sign up

Export Citation Format

Share Document